# Asbestos Disease Initiation

**Authors:** Alisa DeStefano, Clyde Martin, Dorothy Wallace

PMC · DOI: 10.1007/s11538-026-01605-7 · Bulletin of Mathematical Biology · 2026-02-19

## TL;DR

This paper presents a model explaining how asbestos exposure leads to plaque formation and mesothelioma, showing how immune responses and exposure levels influence disease risk.

## Contribution

The paper introduces a novel model integrating wound healing and asbestos transport to simulate disease initiation and progression.

## Key findings

- Cancer and plaque development depend on total asbestos exposure (intensity and duration).
- Plaque deposition is influenced by many systemic parameters, suggesting potential risk-assessment assays.
- Tumor development is sensitive only to exposure and T-cell levels, indicating possible immune interventions.

## Abstract

A model is developed of disease initiation and progression for asbestos related plaque deposition and mesothelioma based on prior models of wound healing and asbestos transport. The model includes short term processes such as macrophage polarization and immune system response, extending the time frame to that of detectable disease. Model results were in a biologically reasonable range. Cancer development and plaque deposition are shown to be dependent on total exposure (intensity * duration). Plaque deposition was sensitive to many systemic parameters, suggesting that assays could be developed to identify individuals with higher risk. Tumor development was sensitive only to a few parameters describing exposure and T-cell levels, indicating potential for immune system intervention.

## Linked entities

- **Diseases:** mesothelioma (MONDO:0005065)

## Full-text entities

- **Genes:** KRT75 (keratin 75) [NCBI Gene 9119] {aka CK-75, K6HF, K75, KB18, PFB, hK6hf}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** Programmed Necrosis (MESH:D009336), infectious disease (MESH:D003141), Asbestos Disease (MESH:D001195), inflammatory cytokines (MESH:D000080424), Mesothelioma (MESH:D008654), infection (MESH:D007239), AIS (MESH:D013734), anemia (MESH:D000740), death (MESH:D003643), pleural mesothelioma (MESH:D000086002), MM (MESH:C535700), Cancer (MESH:D009369), plaques (MESH:D003773), pleural plaques (MESH:D010995), Fibrosis (MESH:D005355), Inflammatory (MESH:D007249), skin wounds (MESH:D014947), skin injury (MESH:D000069836), MO (MESH:D007948)
- **Chemicals:** ROS (MESH:D017382), th (MESH:D013910), Asbestos (MESH:D001194), Bayadilov (-), F (MESH:D005461), crocidolite (MESH:D017638), Fe (MESH:D007501), M2 (MESH:C034584)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917034/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917034/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917034/full.md

---
Source: https://tomesphere.com/paper/PMC12917034